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Background: Recently, the Kidney Disease Improving Global Outcomes (KDIGO) guideline proposed that we should add albuminuria to estimated 
glomerular filtration rate (eGFR) in classifying chronic kidney disease. However, only a few studies using the KDIGO classification are available in 
hospitalized patients due to heart failure (HF). We investigated whether the KDIGO classification has incremental prognostic value in such patients. 
methods: We studied 137 consecutive patients who hospitalized due to HF. Blood and urinary samples were obtained at discharge. Patients 
were categorized by KDIGO classification into 4 groups according to the eGFR and the urinary albumin-to-creatinine ratio as preserved, mild, 
moderate, and severe kidney dysfunction groups. These patients were followed prospectively regarding the occurrence of either all-cause mortality 
and re-hospitalizations due to HF. Cut-off value of the other biomarkers for prediction of the events was identified using ROC curves. Kaplan-Meier 
event curves were compared using log-rank tests. Multivariate Cox proportional hazard analysis was adjusted for age, gender, body mass index, left 
ventricular (LV) ejection fraction, prevalence of hypertension or diabetes mellitus, administrated drugs, B-type natriuretic peptide and significant 
parameters. 
results: Patients were followed for a median of 8.6 months. 23 patients died and 38 were re-hospitalized due to HF. KDIGO classification, 
hemoglobin, administration of calcium channel blocker, and troponin-T levels were predictors of combined all-cause mortality and HF re-
hospitalization (log lank, p<0.0001, p=0.0008, p=0.0013, and p=0.0041, respectively). In multivariate Cox proportional hazard analysis, only KDIGO 
classification and hemoglobin were the predictors of the event (p=0.007, hazard ratio 2.1, 95% confidence interval 1.83 to 2.39, and p=0.006, 
hazard ratio 0.75, 95% confidence interval 0.64 to 0.85, respectively). 
conclusions: This study demonstrates that KDIGO classification is promising to predict mortality and HF re-hospitalization in HF patients 
independent of LV dysfunction and anemia.
